CLINICAL RESEARCH: INTERVENTIONAL CARDIOLOGY
Endovascular Therapy for Chronic Mesenteric Ischemia
Jose A. Silva, MD, FACC*,*,
Christopher J. White, MD, FACC*,
Tyrone J. Collins, MD, FACC*,
J. Stephen Jenkins, MD, FACC*,
Malcolm E. Andry, MD ,
John P. Reilly, MD, FACC* and
Stephen R. Ramee, MD, FACC*
* Department of Cardiology, Section of Gastroenterology, Ochsner Clinic Foundation, New Orleans, Louisiana
Department of Medicine, Section of Gastroenterology, Ochsner Clinic Foundation, New Orleans, Louisiana
Manuscript received July 20, 2005;
revised manuscript received September 21, 2005,
accepted October 3, 2005.
* Reprint requests and correspondence: Dr. Jose A. Silva, Department of Cardiology, Ochsner Clinic Foundation, Slidell Clinic, 2750 Gause Boulevard, Slidell, Louisiana 70461 (Email: jsilva{at}ochsner.org).
OBJECTIVES: We sought to describe the outcomes of a consecutive series of patients with chronic mesenteric ischemia (CMI) who were treated with percutaneous stent revascularization.
BACKGROUND: Historically, the treatment for CMI has been surgical revascularization. However, surgery carries a significant procedural complication rate and mortality.
METHODS: Fifty-nine consecutive patients with CMI underwent stent placement in 79 stenotic (>70%) mesenteric arteries. All patients had clinical follow-up and 90% had anatomical follow-up with angiography (computed tomography or conventional) or ultrasound at 6 months after the procedure.
RESULTS: Procedural success was obtained in 96% (76 of 79 arteries) and symptom relief occurred in 88% (50 patients). At a mean follow-up of 38 ± 15 months (range, 6 to 112 months), 79% of the patients remained alive, and 17% (n = 10) experienced a recurrence of symptoms. Angiography or ultrasound obtained at 14 ± 5 months after the procedure demonstrated a restenosis rate of 29% (n = 20). All patients with recurrent symptoms had angiographic in-stent restenosis and were successfully revascularized percutaneously.
CONCLUSIONS: Percutaneous stent placement for the treatment of CMI can be performed with a high procedural success and a low complication rate. The long-term freedom from symptoms and vascular patency are comparable with surgical results. The inherent lower procedural morbidity and mortality makes the endovascular approach the preferred revascularization technique for these patients.
|
Abbreviations and Acronyms
| | CMI = chronic mesenteric ischemia | | CTA = angiographic computed tomography | | SMA = superior mesenteric artery | | TVR = target vessel revascularization |
|
This article has been cited by other articles:

|
 |

|
 |
 
R. S. M. Davies, M. L. Wall, S. H. Silverman, M. H. Simms, R. K. Vohra, A. W. Bradbury, and D. J. Adam
Surgical Versus Endovascular Reconstruction for Chronic Mesenteric Ischemia: A Contemporary UK Series
Vascular and Endovascular Surgery,
April 1, 2009;
43(2):
157 - 164.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
S. R. Dixon, C. L. Grines, and W. W. O'Neill
The Year in Interventional Cardiology
J. Am. Coll. Cardiol.,
July 17, 2007;
50(3):
270 - 285.
[Full Text]
[PDF]
|
 |
|
|